Podcast
Daily Cardiology
Hosted by Daily Cardiology Academy · FA
to enjoy learning and progressing in cardiometabolic practice
34episodes
Episodes
Newest firstAll episodes
Implantable Cardiac Defibrillators in Patients With Severe LV Systolic Dysfunction
Jul 600:03:24Tap to summarize 📚 ESC 2025 Coverage: After myocardial infarction, does a lingering left ventricle warrant an ICD? by Dr. Masoudkabir, Fellowship of Electrophysiology.
Transcribe →
Dapagliflozin in Patients Hospitalized for Heart Failure
Jul 600:03:52Tap to summarize 📚 ESC 2025 Coverage: Bringing SGLT2 inhibitors from clinic to ward, DAPA ACT HF–TIMI 68 asks if timing matters, by Dr. Ranjbar, Fellowship of Heart Failure.
Transcribe →
Helicobacter pylori Screening After Acute Myocardial Infarction
Jul 500:03:47Tap to summarize 📚 ESC 2025 Coverage: Bridging the heart and the gut, by Dr. Afsharkia, Cardiovascular Specialist.
Transcribe →
Outcomes of cardiovascular screening in men aged 60–64 years
Jul 500:05:09Tap to summarize 📚 ESC 2025 Coverage: Screening promises foresight, but does it deliver survival? by Dr. Seifi, Cardiovascular Specialist.
Transcribe →
Home-Based Care for Hypertension in Rural South Africa
Jul 500:05:49Tap to summarize 📚 ESC 2025 Coverage: When the clinic is miles away, care comes knocking, by Dr. Ebrahimi, Cardiovascular Specialist.
Transcribe →
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Jul 300:03:40Tap to summarize 📚 ESC 2025 Coverage: Targeting Hypercontractility in Nonobstructive HCM: A Place for Mavacamten? by Dr. Sharif Kashani, Fellowship of Heart Failure.
Transcribe →
Impact of Drug-Coated Devices in Patients With Peripheral Arterial Disease
Jun 2800:06:12Tap to summarize📚 ESC 2025 Coverage: Do Drug-Coated Devices Offer More Than Just a High Price Tag in PAD? by Dr. Sadeghipour, Interventional Cardiologist.
Transcribe →
High-Dose Influenza Vaccine to Reduce Hospitalizations
Jun 2300:02:16Tap to summarize📚 ESC 2025 Coverage: When the Stakes Are Higher: Exploring Flu Vaccine Potency in Older Populations by Dr. Motaghizadeh, Cardiovascular Specialist.
Transcribe →
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
Jun 2100:04:02Tap to summarize📚 ESC 2025 Coverage: When Three Drugs Aren’t Enough: Exploring Baxdrostat in Resistant Hypertension by Dr. Ghanavati, Cardiovascular Specialist.
Transcribe →
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous co
Jun 1700:04:18Tap to summarize 📚 ESC 2025 Coverage: One Size Doesn’t Fit All: The TAILORED-CHIP Trial Rethinks Dual Antiplatelet Therapy in Complex PCI, by Dr. Bahadori, Cardiovascular Specialist.
Transcribe →